FibroBiologics (FBLG) Change in Receivables (2023)
FibroBiologics' (FBLG) quarterly Change in Receivables came in at $275000.0 in Q1 2023.
Powered by 
Analysis
FibroBiologics (FBLG) Change in Receivables (2023) Analysis & Trends
FibroBiologics (FBLG) has reported Change in Receivables for 1 consecutive years, with $275000.0 the latest figure, recorded in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.22 Bn | 9.38 Bn | 112.79 Mn | 11.97 Mn |
| 2 | CRISPR Therapeutics AG | 5.06 Bn | 5.06 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.73 Bn | 3.43 Bn | 55.72 Mn | 20.36 Mn |
| 4 | Legend Biotech | 3.61 Bn | 2.65 Bn | 251.50 Mn | 1.60 Mn |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.53 Bn | 2.53 Bn | - | - |
| 7 | Precigen | 2.37 Bn | 2.37 Bn | 52.17 Mn | 45.46 Mn |
| 8 | Sarepta Therapeutics | 2.24 Bn | 1.44 Bn | 251.87 Mn | -17.99 Mn |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn | 3.33 Mn |
| 10 | FibroBiologics | 10.82 Mn | 10.82 Mn | - | - |